Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Cancer

Daily pill can double survival time for world’s deadliest cancer, trial shows

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer

The Guardian - UK

World faces cancer workforce crisis with 100m staff shortfall, report warns

Researchers say healthcare systems could be overwhelmed by 2050 as global burden of disease continues to rise

The Guardian - UK

New cancer pill almost doubles survival time for pancreatic patients during trial

Daraxonrasib has been hailed as ‘landscape-changing’ for people with the disease

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

New pill helps double survival time for people with advanced pancreatic cancer

The drug also had fewer side-effects when compared to chemotherapy, according to a trial.

Evening Standard

Novartis experimental actinium-based drug shows promise in prostate cancer treatment: Study

Novartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, even in patients who previously received Novartis' Pluvicto. Response rates were higher in patients without prior Pluvicto treatment. Larger trials are planned to assess side effects. Novartis is increasing its focus on radioligand…

The Economic Times

New cancer jab returns ‘unprecedented’ results in major clinical trial

IN FULL

The Independent UK

'Unprecedented' cancer jab can destroy whole tumours

An injection that can eradicate tumours in patients with very limited treatment options has been hailed by cancer specialists after an international trial.

AAP

Read news from The Economist, FT, and more,
with one subscription

Doctors hail cancer injection that can destroy entire tumors

The results of the trial will be presented during the American Society of Clinical Oncology annual meeting in Chicago

The Independent UK

Cancer jabs destroy whole tumours in treatment-resistant cases, trial shows

Head and neck cancer is the sixth most common cancer worldwide, and it affects around 12,800 people in the UK each year.

Evening Standard

Cancer jab eradicates entire tumours in breakthrough trial

It shrank the tumours for 42 per cent of patients in the Institute of Cancer Research

The Independent UK

Cancer jab can eradicate entire tumours in patients, trial shows

Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy

The Guardian - UK

Promising bowel cancer drug gives patient ‘new lease of life’

IN FULL

The Independent UK

New bowel cancer drug halts tumour growth in nine out of 10 patients

The drug works by triggering the ‘death’ of cancer cells while largely sparing healthy tissue

The Independent UK

Targeted drug shows promise for people with advanced bowel cancer in early trial

One patient taking part in the trial said the therapy has given her a ‘new lease of life’.

Evening Standard

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Cancer-detecting blood test ‘feasible at scale’ on NHS

IN FULL

The Conversation

Poop tests and blood tests join colonoscopy as options for colorectal cancer screening

It’s increasingly common to see headlines and social media conversations about the rise in colorectal cancer among younger adults. In fact, the growing incidence of colorectal cancer in people under age 50 helped drive the American Cancer Society’s 2018 decision to recommend lowering the recommended age for average-risk screening from…

The Guardian - UK

Trial of multi-cancer blood test among 142,000 NHS patients fails to meet main aim

Results presented at oncology conference in Chicago show Galleri test failed to reduce late-stage cancer diagnoses

The Independent UK

New blood test ‘offers genuine hope’ it can detect deadly cancers before symptoms appear

The test is ‘feasible at scale’ on the NHS, say researchers

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

Galleri blood test ‘feasible at scale’ on NHS, say experts

The NHS-Galleri trial is exploring how well the blood test works within the health service, alongside screening, to pick up cancer cases earlier.

MarketBeat

IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

IDEXX Laboratories (NASDAQ:IDXX) President and CEO Michael Erickson used a Stifel investor conference appearance to emphasize the company’s innovation pipeline, expanding commercial reach and growing use of software and artificial intelligence across veterinary diagnostics. Erickson, who recently b

The Independent UK

Revolutionary test spares millions of cancer patients from chemotherapy

IN FULL

Woman & Home

‘I wonder if there’s a link between us?’: Amy Dowden emotionally discovers her great grandmother died from breast cancer in her 30s

The Strictly star made the discovery during an episode of Who Do You Think You Are?

The Guardian - UK

Poor sleep linked to rising cancer risk in under-50s

Findings add to growing efforts to explain why cancer rates are increasing among younger adults worldwide

The Independent UK

Millions of breast cancer patients could avoid chemotherapy with new genome test

Doctors said the test shows people with certain forms of the disease can safely avoid chemotherapy

The Independent UK

New research finds link between obesity and breast cancer risks

Some 321,910 new cases of invasive breast cancer are estimated to be diagnosed this year

1 … 43 44 45 46

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

American Cancer Society

The Royal Marsden NHS Foundation Trust

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.